Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer

[1]  L. Stodieck,et al.  Microarray analysis of spaceflown murine thymus tissue reveals changes in gene expression regulating stress and glucocorticoid receptors , 2010, Journal of cellular biochemistry.

[2]  M. Fernö,et al.  Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer , 2009, Modern Pathology.

[3]  Prakash Kulkarni,et al.  Down‐regulating cold shock protein genes impairs cancer cell survival and enhances chemosensitivity , 2009, Journal of cellular biochemistry.

[4]  M. Wakabayashi,et al.  Current Status on Biologic Therapies in the Treatment of Epithelial Ovarian Cancer , 2009, Current treatment options in oncology.

[5]  F. Pontén,et al.  The Human Protein Atlas—a tool for pathology , 2008, The Journal of pathology.

[6]  R. Tothill,et al.  Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome , 2008, Clinical Cancer Research.

[7]  R. Postier,et al.  Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe , 2008, Oncogene.

[8]  Kalle Jonasson,et al.  A whole‐genome bioinformatics approach to selection of antigens for systematic antibody generation , 2008, Proteomics.

[9]  L. Kèlland,et al.  The resurgence of platinum-based cancer chemotherapy , 2007, Nature Reviews Cancer.

[10]  Marina Pollán,et al.  Positive correlation between the expression of X‐chromosome RBM genes (RBMX, RBM3, RBM10) and the proapoptotic Bax gene in human breast cancer , 2006, Journal of cellular biochemistry.

[11]  Erik K. Malm,et al.  A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics* , 2005, Molecular & Cellular Proteomics.

[12]  F. Pontén,et al.  Towards a human proteome atlas: High‐throughput generation of mono‐specific antibodies for tissue profiling , 2005, Proteomics.

[13]  Robert D Cardiff,et al.  The transcriptional repressor Snail promotes mammary tumor recurrence. , 2005, Cancer cell.

[14]  Dong Wang,et al.  Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.

[15]  T. Herzog.  Recurrent Ovarian Cancer , 2004, Clinical Cancer Research.

[16]  L. Poellinger,et al.  Induction of ID2 Expression by Hypoxia-inducible Factor-1 , 2004, Journal of Biological Chemistry.

[17]  R. Kirschner,et al.  Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism , 2004, Journal of Cell Science.

[18]  Z. Siddik,et al.  Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.

[19]  M. Picardo,et al.  Identification of genes down‐regulated during melanoma progression: a cDNA array study , 2003, Experimental dermatology.

[20]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[21]  D. Rubinsztein,et al.  Modulation of polyglutamine-induced cell death by genes identified by expression profiling. , 2002, Human molecular genetics.

[22]  H. Pinedo,et al.  Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin. , 2002, Gynecologic oncology.

[23]  S. Dellis,et al.  Vaccinia Virus Late Transcription Is Activated in Vitro by Cellular Heterogeneous Nuclear Ribonucleoproteins* , 2001, The Journal of Biological Chemistry.

[24]  J. Fujita,et al.  Decreased expression of mouse Rbm3, a cold-shock protein, in Sertoli cells of cryptorchid testis. , 2000, The American journal of pathology.

[25]  S. Lippard,et al.  Structure, Recognition, and Processing of Cisplatin-DNA Adducts. , 1999, Chemical reviews.

[26]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[27]  T. Matsuda,et al.  Increased transcript level of RBM3, a member of the glycine-rich RNA-binding protein family, in human cells in response to cold stress. , 1997, Biochemical and biophysical research communications.

[28]  K. Eriksson,et al.  Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmö Preventive Project , 1996, Journal of internal medicine.

[29]  U. Francke,et al.  RBM3, a novel human gene in Xp11.23 with a putative RNA-binding domain. , 1995, Human molecular genetics.

[30]  C. Burd,et al.  Conserved structures and diversity of functions of RNA-binding proteins. , 1994, Science.

[31]  G. Berglund,et al.  Design and feasibility , 1993 .

[32]  K. Seeger,et al.  The RNA-Binding Protein RBM3 Is Required for Cell Proliferation and Protects Against Serum Deprivation-Induced Cell Death , 2010, Pediatric Research.

[33]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[34]  L. Sutherland,et al.  RNA binding motif (RBM) proteins: A novel family of apoptosis modulators? , 2005, Journal of cellular biochemistry.

[35]  Weizhong Li,et al.  Seasonally hibernating phenotype assessed through transcript screening. , 2005, Physiological genomics.

[36]  G. Berglund,et al.  The Malmo Diet and Cancer Study. Design and feasibility. , 1993, Journal of internal medicine.